Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024 GlobeNewswire - Wed Nov 6, 6:30AM CST

OCUL : 10.78 (-1.46%)
Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD GlobeNewswire - Tue Oct 15, 6:30AM CDT

OCUL : 10.78 (-1.46%)
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Wed Oct 9, 3:05PM CDT

OCUL : 10.78 (-1.46%)
Ocular Therapeutix™ to Present at October Ophthalmology Meetings GlobeNewswire - Wed Oct 9, 6:30AM CDT

OCUL : 10.78 (-1.46%)
Ocular Therapeutix: Q2 Earnings Snapshot AP - Wed Aug 7, 6:38AM CDT

Ocular Therapeutix: Q2 Earnings Snapshot

OCUL : 10.78 (-1.46%)
Wall Street - shutterstock_156562427
3 Standout Stocks Under $10 With 86% Upside Potential or More Barchart - Wed Jul 24, 7:59AM CDT

As the chances for a September rate cut grow even stronger, these three penny stocks can emerge as substantial wealth creators.

AMZN : 210.05 (+1.43%)
AAPL : 227.48 (+2.14%)
NVDA : 148.88 (+2.25%)
OPAL : 3.85 (unch)
OCUL : 10.78 (-1.46%)
NUVB : 2.62 (+3.15%)
Ocular Therapeutix: Q1 Earnings Snapshot AP - Tue May 7, 3:41PM CDT

Ocular Therapeutix: Q1 Earnings Snapshot

OCUL : 10.78 (-1.46%)
2 Small-Cap Growth Stocks With Room To Run Motley Fool - Wed Apr 24, 7:30AM CDT

These two small-cap growth stocks could be ready to run.

REGN : 824.48 (+0.96%)
RHHBY : 38.1700 (+1.06%)
ACHR : 3.50 (+9.03%)
OCUL : 10.78 (-1.46%)
Ocular Therapeutix: Q4 Earnings Snapshot AP - Mon Mar 11, 3:26PM CDT

Ocular Therapeutix: Q4 Earnings Snapshot

OCUL : 10.78 (-1.46%)
Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024 Motley Fool - Wed Jan 3, 12:15PM CST

These two biotech stocks sport notable 12-month price targets. However, they are also uber-risky.

BIIB : 173.92 (-0.28%)
XBI : 103.01 (+0.56%)
XLK : 237.42 (+1.74%)
OCUL : 10.78 (-1.46%)
LRMR : 9.12 (+11.76%)

Barchart Exclusives

Brookfield is Still Rising Barchart - 19 minutes ago
Summary Brookfield Asset Management (BAM) shows strong technical indicators with 100% buy signals, 84.64+ Weighted Alpha, and a 33.49% gain since 8/27. The firm specializes in alternative asset management across renewable energy, infrastructure, private equity, real estate, credit, and insurance sectors. Fundamental factors are robust with a $25.31 billion market... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot